相似文献
1
An optimal dose-fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early-stage non-small lung cancer.
Thorac Cancer. 2023 Oct;14(28):2813-2820. doi: 10.1111/1759-7714.15071. Epub 2023 Sep 10.
2
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
J Thorac Oncol. 2015 Apr;10(4):577-85. doi: 10.1097/JTO.0000000000000453.
3
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27.
4
SBRT for centrally localized NSCLC - What is too central?
Radiat Oncol. 2016 Dec 3;11(1):157. doi: 10.1186/s13014-016-0732-5.
5
Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea.
Cancer Res Treat. 2017 Jul;49(3):688-694. doi: 10.4143/crt.2016.219. Epub 2016 Oct 31.
6
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Radiat Oncol. 2015 May 15;10:113. doi: 10.1186/s13014-015-0417-5.
7
[Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):413-418. doi: 10.3779/j.issn.1009-3419.2018.05.10.
8
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.
9
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Clin Lung Cancer. 2019 Jan;20(1):e63-e71. doi: 10.1016/j.cllc.2018.09.004. Epub 2018 Sep 20.
10
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.
Br J Radiol. 2015 Jul;88(1051):20150036. doi: 10.1259/bjr.20150036. Epub 2015 Apr 15.
引用本文的文献
1
Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis.
Transl Lung Cancer Res. 2024 Dec 31;13(12):3616-3628. doi: 10.21037/tlcr-24-992. Epub 2024 Dec 27.
2
Stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical early-stage non-small-cell lung cancer: a population-based study.
Thorac Cancer. 2024 Aug;15(24):1779-1791. doi: 10.1111/1759-7714.15404. Epub 2024 Jul 16.
本文引用的文献
1
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Lung Cancer. 2023 Aug;182:107281. doi: 10.1016/j.lungcan.2023.107281. Epub 2023 Jun 21.
2
Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done.
Cancers (Basel). 2022 Feb 3;14(3):790. doi: 10.3390/cancers14030790.
3
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
Lancet Oncol. 2021 Oct;22(10):1448-1457. doi: 10.1016/S1470-2045(21)00401-0. Epub 2021 Sep 13.
4
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy.
Acta Oncol. 2021 Aug;60(8):1061-1068. doi: 10.1080/0284186X.2021.1942545. Epub 2021 Jun 30.
5
Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer.
Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):436-442. doi: 10.1016/j.ijrobp.2021.05.116. Epub 2021 May 26.
6
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.
Adv Radiat Oncol. 2021 Jan 20;6(2):100653. doi: 10.1016/j.adro.2021.100653. eCollection 2021 Mar-Apr.
7
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
J Thorac Oncol. 2021 Jul;16(7):1200-1210. doi: 10.1016/j.jtho.2021.03.019. Epub 2021 Apr 3.
8
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer.
Semin Radiat Oncol. 2021 Apr;31(2):124-132. doi: 10.1016/j.semradonc.2020.11.009.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Long-term Overall Survival Outcomes in Patients with Early Stage, Peripherally Located, Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy in a Non-academic Cancer Centre.
Clin Oncol (R Coll Radiol). 2021 May;33(5):283-291. doi: 10.1016/j.clon.2020.12.001. Epub 2020 Dec 16.
Zotero 插件